A bitter war for control of ConMed (NSDQ:CNMD) is heating up as the medical device company's annual meeting looms, with 2 hedge funds pressing hard to win shareholders' votes for their respective board nominees.
Utica, N.Y.-based ConMed's shareholders meeting is slated for Sept. 10. As the date approaches, ConMed and ally Coppersmith Capital Management are vying with Voce Capital Management to have their respective slates elected to the board. The battle over ConMed dates back to at least last November, when Voce demanded that the company take steps toward a strategic exit and end "a culture of nepotism, patronage and dystopian corporate governance."
Help employers find you! Check out all the jobs and post your resume.
